[ 19 ] The SMASH-VT trial, a non-blinded randomized controlled study, suggested a potential reduction in mortality in the catheter ablation group; however, the difference did not reach statistical significance.
← all excerpts
Incremental benefits of catheter ablation in patients with structural heart disease undergoing implantable cardioverter-defibrillator therapy for ventricular arrhythmias: A PRISMA compliant systematic review and meta analysis.
1
—
—